Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Malignant Lymphoma

Free Subscription Articles published in Br J Dermatol Retrieve available abstracts of 33 articles: HTML format

Single Articles

September 2025
1. HODAK E, Amitay-Laish I, Bagot M, Battistella M, et al
   ISCL/EORTC-CLTG/USCLC recommendations for the diagnosis, staging and treatment of early-stage paediatric mycosis fungoides: a modified Delphi consensus. Part two: treatment.
   Br J Dermatol. 2025;193:653-661.
   PubMed     Abstract available
   
   
   
2. GHOSH S, Pavlova O, Latshaw A, Kim D, et al
   Multi-Harmonic Imaging-Based Automated Recognition of Cutaneous T-Cell Lymphoma.
   Br J Dermatol. 2025 Sep 4:ljaf345. doi: 10.1093.
   PubMed     Abstract available
   
   
   August 2025
3. HODAK E, Amitay-Laish I, Bagot M, Battistella M, et al
   ISCL/EORTC-CLTG/USCLC recommendations for the diagnosis, staging and treatment of early-stage paediatric mycosis fungoides: a modified Delphi consensus. Part one: diagnosis and staging.
   Br J Dermatol. 2025;193:405-414.
   PubMed     Abstract available
   
   
   June 2025
4. IVERT LU, Ekberg S, Smedby KE, Brauner H, et al
   Increased mortality due to lymphoma and infections in patients with mycosis fungoides or Sezary syndrome: A Swedish nationwide, population-based cohort study.
   Br J Dermatol. 2025 Jun 19:ljaf233. doi: 10.1093.
   PubMed    
   
   
   May 2025
5. DOELEMAN T, Beljaards ESM, Ottevanger R, Jansen P, et al
   Added value of pathology consultations in cutaneous lymphomas: a 2-year review from the Dutch national referral and expertise centre.
   Br J Dermatol. 2025 May 14:ljaf184. doi: 10.1093.
   PubMed     Abstract available
   
   
   April 2025
6. PILERI A, Zengarini C
   Harnessing Extracorporeal Photopheresis to Trigger Immunogen Cell Death: A Bounty on Cutaneous Lymphoma Cells.
   Br J Dermatol. 2025 Apr 12:ljaf138. doi: 10.1093.
   PubMed    
   
   
   March 2025
7. BAGOT M
   Therapeutic advances for Cutaneous T Cell Lymphoma.
   Br J Dermatol. 2025 Mar 22:ljaf105. doi: 10.1093.
   PubMed     Abstract available
   
   
   
8. LACKNER A, Burner T, Brandner M, Dey S, et al
   Evidence of Immunogenic Cell Death (ICD) and ICD-dependent Dendritic Cell Activation Induced by Extracorporeal Photopheresis in Patients with leukemic forms of cutaneous T cell lymphoma.
   Br J Dermatol. 2025 Mar 20:ljaf102. doi: 10.1093.
   PubMed     Abstract available
   
   
   February 2025
9. COSTANZA M, Giordano C, von Brunneck AC, Zhao J, et al
   Preclinical in vitro and in vivo evidence for CD74-targeting as effective treatment strategy for cutaneous T cell lymphomas.
   Br J Dermatol. 2025 Feb 27:ljaf001. doi: 10.1093.
   PubMed     Abstract available
   
   
   
10. OTTEVANGER R, Vermeer MH
    Cutaneous T-cell lymphoma in Australia: what drives geospatial?
    Br J Dermatol. 2025 Feb 22:ljaf026. doi: 10.1093.
    PubMed    
    
    
    
11. GNIADECKI R, Guenova E, Querfeld C, Nicolay JP, et al
    Haematogenous seeding in mycosis fungoides and Sezary syndrome: current evidence and clinical implications.
    Br J Dermatol. 2025;192:381-389.
    PubMed     Abstract available
    
    
    
12. WEHKAMP U, Pietzka S, Kotrova M, Jost M, et al
    Mycosis fungoides: differentiation from inflammation and detection of circulating tumour cells with the EuroClonality next-generation sequencing assay.
    Br J Dermatol. 2025;192:492-500.
    PubMed     Abstract available
    
    
    January 2025
13. GNIADECKI R
    Chaperoning a Cure: Unexpected Role of CD74 in Cutaneous T-cell lymphoma.
    Br J Dermatol. 2025 Jan 29:ljaf040. doi: 10.1093.
    PubMed    
    
    
    December 2024
14. BONTOUX C, Badrignans M, Afach S, Sbidian E, et al
    Pustular mycosis fungoides has a poor outcome: a multicentric clinicopathological and molecular case series.
    Br J Dermatol. 2024;192:125-134.
    PubMed     Abstract available
    
    
    
15. CAMPBELL BA, Baade PD, Dasgupta P, Cameron JK, et al
    Geospatial analyses demonstrate variation of cutaneous T-cell lymphomas across Australia, providing insights into possible causes.
    Br J Dermatol. 2024 Dec 6:ljae476. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2024
16. BLANCHARD G, Atallah I, Blanchard M, Fehrenbacher B, et al
    Primary cutaneous T-cell lymphoma not otherwise specified (NOS) uncovering a novel RAB27A variant in Griscelli syndrome type 2.
    Br J Dermatol. 2024 Oct 21:ljae412. doi: 10.1093.
    PubMed    
    
    
    September 2024
17. TENSEN CP, Vermeer MH
    Single cell analyses of cutaneous T-cell lymphoma biopsies.
    Br J Dermatol. 2024 Sep 13:ljae351. doi: 10.1093.
    PubMed    
    
    
    August 2024
18. STADLER R
    The interferon story continues: EORTC CLTG study explores pegylated interferon alpha-2a's role in treating mycosis fungoides/Sezary syndrome.
    Br J Dermatol. 2024;191:321-322.
    PubMed    
    
    
    
19. MITSUNAGA K, Bagot M, Ram-Wolff C, Guenova E, et al
    Real-world study of pegylated interferon alpha-2a to treat mycosis fungoides/Sezary syndrome using time to next treatment as a measure of clinical benefit: an EORTC CLTG study.
    Br J Dermatol. 2024;191:419-427.
    PubMed     Abstract available
    
    
    
20. CHENNAREDDY S, Rindler K, Ruggiero JR, Alkon N, et al
    Single-cell RNA sequencing comparison of CD4+, CD8+ and TCR-gammadelta+ cutaneous T-cell lymphomas reveals subset-specific molecular phenotypes.
    Br J Dermatol. 2024 Aug 12:ljae313. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2024
21. RAYMUNDO C, Cella D, Wagner L, Hippe DS, et al
    Development and psychometric properties of the Functional Assessment of Cancer Therapy-Cutaneous T-Cell Lymphoma (FACT-CTCL).
    Br J Dermatol. 2024 Jul 30:ljae308. doi: 10.1093.
    PubMed     Abstract available
    
    
    
22. BATTISTELLA M
    Paediatric lymphomatoid papulosis: a benign clonal T-cell disorder that is a harbinger of haematological malignancy.
    Br J Dermatol. 2024;191:158-159.
    PubMed    
    
    
    June 2024
23. WOBSE M, Appenzeller S, Roth S, Siedel C, et al
    Oncogenic alterations in KIR3DL1 in cutaneous acral CD8+ lymphoproliferative disorder.
    Br J Dermatol. 2024 Jun 27:ljae256. doi: 10.1093.
    PubMed     Abstract available
    
    
    
24. TZOUMPA S, Ingen-Housz-Oro S, de Masson A, Pham-Ledard A, et al
    Evolution of patients with Sezary syndrome after mogamulizumab discontinuation for any cause except progression: a multicentre retrospective study (Moga-stop Study).
    Br J Dermatol. 2024;191:143-144.
    PubMed    
    
    
    May 2024
25. JAMES M, Nakamura M, Whittaker S, Morris S, et al
    Mycosis fungoides: successful re-treatment with brentuximab vedotin.
    Br J Dermatol. 2024;190:929-930.
    PubMed    
    
    
    
26. RODRIGUEZ M, Rebollo-Gonzalez M, Frutos Diaz-Alejo J, Manso R, et al
    Mutational profiling of Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders do not resemble nodal peripheral T-cell lymphomas with follicular helper T-cell phenotype.
    Br J Dermatol. 2024 May 13:ljae192. doi: 10.1093.
    PubMed    
    
    
    April 2024
27. BLANCHARD M, Morren MA, Busschots AM, Hauben E, et al
    Paediatric onset lymphomatoid papulosis: results of a multicentre retrospective cohort study, on behalf of the EORTC Cutaneous Lymphoma Tumours Group (CLTG).
    Br J Dermatol. 2024 Apr 10:ljae150. doi: 10.1093.
    PubMed     Abstract available
    
    
    
28. ROCCUZZO G, Calvao J, Dobos G, Morsia E, et al
    Cutaneous T-cell lymphoma care across Europe: insights from the Horizon Project.
    Br J Dermatol. 2024 Apr 5:ljae145. doi: 10.1093.
    PubMed    
    
    
    February 2024
29. STAMMLER R, Ta VA, Cohen E, Ram-Wolff C, et al
    Failure of second challenge with Mogamulizumab in CCR4-positive cutaneous T-cell lymphoma.
    Br J Dermatol. 2024 Feb 23:ljae085. doi: 10.1093.
    PubMed    
    
    
    
30. JUNG JM, Cho HS, Kim GH, Won CH, et al
    Psoriasiform mycosis fungoides: a clinical and prognostic retrospective cohort study.
    Br J Dermatol. 2024;190:432-434.
    PubMed    
    
    
    January 2024
31. TRUM NA, Chen L, Zain J, Rosen ST, et al
    Significant survival disparity in Black patients with cutaneous lymphoma: a retrospective cohort study.
    Br J Dermatol. 2024 Jan 29:ljae039. doi: 10.1093.
    PubMed    
    
    
    October 2023
32. 
    Multiple skin lesions, especially on the legs, predict a poorer prognosis in skin lymphoma with large tumour cells.
    Br J Dermatol. 2023;189:e98.
    PubMed    
    
    
    
33. 
    The effect of extracorporeal photopheresis on cytokines released by leukaemic cutaneous T-cell lymphoma.
    Br J Dermatol. 2023;189:e97.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.